Current Research & Future Challenges

Vaccine development remains challenging because of the highly sophisticated evasion mechanisms of pathogens for which vaccines are not yet available. Recent years have witnessed both successes and failures of novel vaccine design and the strength of iterative approaches is increasingly appreciated. These combine discovery of novel antigens, adjuvants and vectors in the preclinical stage with computational analyses of clinical data to accelerate vaccine design. Reverse and structural vaccinology have revealed novel antigen candidates and molecular immunology has led to the formulation of promising adjuvants. Gene expression profiles and immune parameters in patients, vaccines and healthy controls have formed the basis for bio-signatures that will provide guidelines for future vaccine design.

  • Immunological challenges
  • Antigen discovery
  • Immunization routes
  • Aspects of pathology and host responses
  • Expanded testing and modeling of vaccine
  • Chloroplast-derived vaccines antigens and therapeutics
  • Chloroplast-derived viral antigens

Related Conference of Current Research & Future Challenges

September 18-19, 2017

20th Global Summit & Expo on Vaccines, Immunization & B2B

(Global B2B Meetings in 1 Event) Houston, Texas USA
October 30-31, 2017

19th International Vaccines & B2B Congress

Chicago, USA

Current Research & Future Challenges Conference Speakers

Recommended Sessions

Related Journals

Are you interested in